Related Experiment Videos
Ubiquitin, proteasomes, and the aging brain
Douglas A Gray1, Maria Tsirigotis, John Woulfe
1Ottawa Regional Cancer Centre, Ottawa, Ontario, Canada K1H 1C4. Doug.Gray@orcc.on.ca
Science of Aging Knowledge Environment : SAGE KE
|August 29, 2003
Summary
Age-related decline in the ubiquitin/proteasome pathway (UPP) function may contribute to neurodegeneration. This study reviews evidence linking aging, UPP dysfunction, and protein aggregation in the mammalian brain.
Area of Science:
- Neuroscience
- Molecular Biology
- Aging Research
Background:
- Ubiquitinated protein inclusions characterize neurodegenerative diseases.
- Inefficient proteolysis can cause toxic protein accumulation.
- Genetic evidence links ubiquitin/proteasome system (UPS) defects to disease.
Purpose of the Study:
- Investigate age-related decline in the ubiquitin/proteasome pathway (UPP).
- Examine if UPP decline correlates with protein aggregation in aging brains.
- Review evidence for age-related changes in UPP components.
Main Methods:
- Review of existing literature on aging and the UPP.
- Analysis of studies showing alterations in the aging mammalian brain.
- Correlation of UPP function decline with protein accumulation.
Main Results:
- Aging mammalian brains exhibit alterations linked to UPP functional decline.
- Evidence suggests age-related changes in specific UPP components.
- Protein aggregation in aging brains may result from impaired UPP.
Conclusions:
- Age-related decline in UPP function is implicated in neurodegeneration.
- Changes in UPP components may contribute to proteinopathies.
- Understanding these changes offers insights into aging and disease mechanisms.